The Janssen Vaccine will not be given to the younger people of the Netherlands, those who have yet to receive a dose of vaccine. Instead of this, they will be taking Pfizer/BioNTech or Moderna, which are approved vaccines, said Health Minister Hugo de Jonge on Wednesday.
According to the Dutch Health Council, this situation leads to a one-week setback to the vaccination program. Jonge and the Council stated that people who received the Janssen Vaccine have no reason to panic because the vaccine is safe and effective. Moreover, this vaccine was established at a laboratory in Leiden, and then later on the Prime Minister Mark Rutte used it this week.
The council mentioned that the mRNA vaccines ”are more effective and have fewer drawbacks” in comparison to AstraZeneca and Johnson & Johnson since both of these vaccines have proved to have side effects such as blood clots and low platelet count. The research center Lareb has not come across any side effect for the dose of Janssen Vaccine.
The Council further mentioned its new policy advisory since the mRNA vaccines are being established and delivered to the Netherlands in big batches, and since the infection rates are currently low. These reasons only mean that ”The Netherlands can afford this choice in the vaccination program.” said the Council.
People born in 1976 are the last group to take the Janssen Vaccine, whereas people that can’t be contacted for the second dose of vaccine such as homeless people, will receive the Janssen vaccine.
Despite all this, the Council still advises for the AstraZeneca vaccine to taken by people of over 60 years. Also, the Health Ministry stated that people who refused to take the AstraZeneca vaccine, they can instead receive one of the mRNA vaccines.
The estimated amount of the Janssen Vaccine doses to be delivered in the Netherlands was around 3 million. However, there were some issues with the delays starting from April, so during the first two months of the quarter, some hundred thousands vaccines were delivered instead.